Abstract
In recent decades, groundbreaking methods of diagnosis and treatment were developed leading to significantly increased life span of patients with malignant neoplasms. Among patients treated for cancer, cardiovascular diseases are the leading cause of death not associated with cancer. Early identification of cardiotoxicity is very important as it allows to apply early prevention measures and modify antitumor treatment schemes. Prevention and treatment of cardiotoxicity are possible only with a functioning multidisciplinary team including oncologists and cardiologists. Magnetic resonance imaging of the heart plays a significant role in monitoring the condition of cardiovascular system during antitumor treatment. This technique allows to obtain accurate characteristics of the tissues and evaluate myocardial perfusion without radiation exposure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
